We know the ins and outs of the complex rare disease market
OPEN Health is highly invested in the delivery of positive outcomes in rare disease. We have extensive experience across our practices having worked with many clients within the area of orphan and ultra-orphan medicine.
Our broad capabilities help us to recognise that every scenario is unique and we therefore apply bespoke, cohesive solutions to ensure optimal outcomes are achieved for our clients and the patients they serve. Over 300 of our 450 staff have direct rare disease experience, and as a group we have partnered with over 20 rare disease-focused companies in the last three years.